STATE STREET CORP

Position in GPCR — Structure Therapeutics Inc.

CIK 93751 BOSTON, MA

Position in GPCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,293,404

-$1,060,575 QoQ

Shares Held

47,581

-1.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. GPCR ranks #231 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,293,404	47,581	-1.3%	Shares	Defined	2026-05-15
2025-12-31	$3,353,979	48,224	+4.8%	Shares	Defined	2026-02-13
2025-09-30	$1,288,476	46,017	+37.5%	Shares	Defined	2025-11-14
2025-06-30	$693,939	33,459	+211.5%	Shares	Defined	2025-08-14
2025-03-31	$185,909	10,740	+2.0%	Shares	Defined	2025-05-15
2024-12-31	$285,492	10,527	-14.4%	Shares	Defined	2025-02-14
2024-09-30	$539,627	12,295	+27.0%	Shares	Defined	2024-11-14
2024-06-30	$380,290	9,684	-23.7%	Shares	Defined	2024-08-14
2024-03-31	$543,936	12,691	-8.9%	Shares	Defined	2024-05-15
2023-12-31	$568,031	13,936	-3.6%	Shares	Defined	2024-02-14
2023-09-30	$729,073	14,460	+26.2%	Shares	Defined	2023-11-14
2023-06-30	$476,392	11,460	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.